Department of Psychosocial and Community Health, University of Washington, Seattle, Washington, USA.
J Am Geriatr Soc. 2011 Aug;59(8):1393-402. doi: 10.1111/j.1532-5415.2011.03519.x. Epub 2011 Jul 28.
To test the effects of walking, light exposure, and a combination intervention (walking, light, and sleep education) on the sleep of persons with Alzheimer's disease (AD).
Randomized, controlled trial with blinded assessors.
Independent community living.
One hundred thirty-two people with AD and their in-home caregivers.
Participants were randomly assigned to one of three active treatments (walking, light, combination treatment) or contact control and received three or six in-home visits.
Primary outcomes were participant total wake time based on wrist actigraphy and caregiver ratings of participant sleep quality on the Sleep Disorders Inventory (SDI). Secondary sleep outcomes included additional actigraphic measurements of sleep percentage, number of awakenings, and total sleep time.
Participants in walking (P=.05), light (P=.04), and combination treatment (P=.01) had significantly greater improvements in total wake time at posttest (effect size 0.51-0.63) than controls but no significant improvement on the SDI. Moderate effect size improvements in actigraphic sleep percentage were also observed in active treatment participants. There were no significant differences between the active treatment groups and no group differences for any sleep outcomes at 6 months. Participants with better adherence (4 d/wk) to walking and light exposure recommendations had significantly less total wake time (P=.006) and better sleep efficiency (P=.005) at posttest than those with poorer adherence.
Walking, light exposure, and their combination are potentially effective treatments for improving sleep in community-dwelling persons with AD, but consistent adherence to treatment recommendations is required.
测试步行、光照和综合干预(步行、光照和睡眠教育)对阿尔茨海默病(AD)患者睡眠的影响。
随机对照试验,盲法评估。
独立社区居住。
132 名 AD 患者及其家庭护理人员。
参与者被随机分配到三种主动治疗(步行、光照、综合治疗)或联系对照组,并接受三次或六次家访。
主要结果是基于腕部活动记录仪的参与者总清醒时间和照顾者对参与者睡眠障碍量表(SDI)的睡眠质量评分。次要睡眠结果包括额外的活动记录仪测量的睡眠百分比、觉醒次数和总睡眠时间。
步行(P=.05)、光照(P=.04)和综合治疗(P=.01)组的参与者在测试后总清醒时间有显著改善(效应大小 0.51-0.63),而对照组没有显著改善,在活动记录仪测量的睡眠百分比方面也观察到了中度效应大小的改善。在积极治疗参与者中,也观察到了睡眠效率的显著改善。在积极治疗组之间没有显著差异,在 6 个月时,任何睡眠结果也没有组间差异。步行和光照暴露建议的依从性(每周 4 天)较好的参与者,在测试后总清醒时间(P=.006)和睡眠效率(P=.005)显著改善。
步行、光照暴露及其组合可能是改善社区居住的 AD 患者睡眠的有效治疗方法,但需要坚持治疗建议。